📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus. (2017)

First Author: Md Yusof MY

Attributed to: Maximising patient benefit: Leeds’ Interdisciplinary approach to translation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2017-211191

PubMed Identifier: 28684557

Publication URI: http://europepmc.org/abstract/MED/28684557

Type: Journal Article/Review

Volume: 76

Parent Publication: Annals of the rheumatic diseases

Issue: 11

ISSN: 0003-4967